Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Altered states: psychedelics and anesthetics.

Icaza EE, Mashour GA.

Anesthesiology. 2013 Dec;119(6):1255-60. doi: 10.1097/01.anes.0000435635.42332.ee.

PMID:
24061599
2.

Psychedelics, glutamate, and neuroimaging studies.

dos Santos RG.

Anesthesiology. 2014 Jun;120(6):1521-2. doi: 10.1097/ALN.0000000000000243. No abstract available.

PMID:
24845923
3.
4.

In reply.

Mashour GA, Icaza EE.

Anesthesiology. 2014 Jun;120(6):1522-3. doi: 10.1097/ALN.0000000000000244. No abstract available.

PMID:
24845924
5.

Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience.

Pokorny T, Preller KH, Kraehenmann R, Vollenweider FX.

Eur Neuropsychopharmacol. 2016 Apr;26(4):756-66. doi: 10.1016/j.euroneuro.2016.01.005. Epub 2016 Jan 22.

PMID:
26875114
6.

The epistemic innocence of psychedelic states.

Letheby C.

Conscious Cogn. 2016 Jan;39:28-37. doi: 10.1016/j.concog.2015.11.012. Epub 2015 Dec 7. Review.

PMID:
26675408
7.

Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin.

Carhart-Harris RL, Erritzoe D, Williams T, Stone JM, Reed LJ, Colasanti A, Tyacke RJ, Leech R, Malizia AL, Murphy K, Hobden P, Evans J, Feilding A, Wise RG, Nutt DJ.

Proc Natl Acad Sci U S A. 2012 Feb 7;109(6):2138-43. doi: 10.1073/pnas.1119598109. Epub 2012 Jan 23.

8.

Broadband cortical desynchronization underlies the human psychedelic state.

Muthukumaraswamy SD, Carhart-Harris RL, Moran RJ, Brookes MJ, Williams TM, Errtizoe D, Sessa B, Papadopoulos A, Bolstridge M, Singh KD, Feilding A, Friston KJ, Nutt DJ.

J Neurosci. 2013 Sep 18;33(38):15171-83. doi: 10.1523/JNEUROSCI.2063-13.2013.

9.

Return of the psychedelics: Psilocybin for treatment resistant depression.

Patra S.

Asian J Psychiatr. 2016 Dec;24:51-52. doi: 10.1016/j.ajp.2016.08.010. Epub 2016 Aug 23. Review.

PMID:
27931907
10.

Enhanced repertoire of brain dynamical states during the psychedelic experience.

Tagliazucchi E, Carhart-Harris R, Leech R, Nutt D, Chialvo DR.

Hum Brain Mapp. 2014 Nov;35(11):5442-56. doi: 10.1002/hbm.22562. Epub 2014 Jul 3.

PMID:
24989126
11.

Psilocybin--summary of knowledge and new perspectives.

Tylš F, Páleníček T, Horáček J.

Eur Neuropsychopharmacol. 2014 Mar;24(3):342-56. doi: 10.1016/j.euroneuro.2013.12.006. Epub 2013 Dec 17. Review.

PMID:
24444771
12.

Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin.

Lebedev AV, Lövdén M, Rosenthal G, Feilding A, Nutt DJ, Carhart-Harris RL.

Hum Brain Mapp. 2015 Aug;36(8):3137-53. doi: 10.1002/hbm.22833. Epub 2015 May 22.

PMID:
26010878
13.

Peak experiences of psilocybin users and non-users.

Cummins C, Lyke J.

J Psychoactive Drugs. 2013 Apr-Jun;45(2):189-94.

PMID:
23909006
14.

The neurobiology of psychedelic drugs: implications for the treatment of mood disorders.

Vollenweider FX, Kometer M.

Nat Rev Neurosci. 2010 Sep;11(9):642-51. doi: 10.1038/nrn2884. Epub 2010 Aug 18. Review.

PMID:
20717121
15.

Alterations of consciousness and mystical-type experiences after acute LSD in humans.

Liechti ME, Dolder PC, Schmid Y.

Psychopharmacology (Berl). 2017 May;234(9-10):1499-1510. doi: 10.1007/s00213-016-4453-0. Epub 2016 Oct 7.

16.

Psychedelics and the science of self-experience.

Nour MM, Carhart-Harris RL.

Br J Psychiatry. 2017 Mar;210(3):177-179. doi: 10.1192/bjp.bp.116.194738.

PMID:
28249943
17.
18.

Phenomenology, Structure, and Dynamic of Psychedelic States.

Preller KH, Vollenweider FX.

Curr Top Behav Neurosci. 2016 Dec 27. doi: 10.1007/7854_2016_459. [Epub ahead of print] Erratum in: Curr Top Behav Neurosci. 2017 Jul 15;:.

PMID:
28025814
19.

The 5-HT2A/1A agonist psilocybin disrupts modal object completion associated with visual hallucinations.

Kometer M, Cahn BR, Andel D, Carter OL, Vollenweider FX.

Biol Psychiatry. 2011 Mar 1;69(5):399-406. doi: 10.1016/j.biopsych.2010.10.002. Epub 2010 Dec 3.

20.

New drugs of abuse.

Graeme KA.

Emerg Med Clin North Am. 2000 Nov;18(4):625-36.

PMID:
11130930

Supplemental Content

Support Center